RNS Number : 9677O
Rentokil Initial PLC
17 May 2024
 

Rentokil Initial plc (the Company)

The Company hereby announces that it has been notified that in respect of the final dividend for 2023, Andy Ransom, a person discharging managerial responsibility, has acquired 7,091 ordinary shares of 1 pence in the Company as a result of his participation in the Company's Dividend Reinvestment Plan (DRIP). The shares were purchased on 16 May 2023 at £4.345000 each.

The notification set out below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Andy Ransom

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Acquisition of shares through the Company's

Dividend Reinvestment Plan (DRIP).

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£4.345000

7,091

d)

 

Aggregated information

 

- Aggregated volume

 

- Total price

 

 

 

7,091 shares

 

£30,810.40

e)

 

Date of the transaction

 

16 May 2024

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

Enquiries:

 

Rachel Canham,Group General Counsel and Company Secretary    

Rentokil Initial plc        +44 (0)1293 858000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBSGDUDGBDGSR